The Library
AVAST-M: Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence
Tools
Tools
Tools
(2013) AVAST-M: Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence. Journal of Clinical Oncology, 31 (15). doi:10.1200/jco.2013.31.15_suppl.lba9000 Research output not available from this repository, contact author.
Official URL: https://doi.org/10.1200/jco.2013.31.15_suppl.lba90...
| Item Type: | Journal Item | ||||
|---|---|---|---|---|---|
| Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) | ||||
| Divisions: | Faculty of Medicine > Warwick Medical School > Health Sciences > Clinical Trials Unit Faculty of Medicine > Warwick Medical School > Health Sciences Faculty of Medicine > Warwick Medical School |
||||
| Journal or Publication Title: | Journal of Clinical Oncology | ||||
| Publisher: | American Society of Clinical Oncology | ||||
| ISSN: | 0732-183X | ||||
| Official Date: | 20 May 2013 | ||||
| Dates: |
|
||||
| Volume: | 31 | ||||
| Number: | 15 | ||||
| DOI: | 10.1200/jco.2013.31.15_suppl.lba9000 | ||||
| Status: | Peer Reviewed | ||||
| Publication Status: | Published | ||||
| Access rights to Published version: | Restricted or Subscription Access |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
